Finance

Lists
Why is NRSN down 6.08%?
Dive Deeper
NRSN:NASDAQ
Neurosense Therapeutics Ltd
$6.95
-6.08%
(-0.45) 1D
$6.95
0.00% (0.00)
After hours
Closed: Sep 25, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NRSN...
Open
$7.18
High
$7.18
Low
$6.73
Mkt. cap
13.18M
Avg. vol.
365.03K
Volume
8.67K
52-wk high
$25.99
52-wk low
$5.00
EPS
-$8.73
Beta
1.60
Shares outstanding
1.90M
No. of employees
17
Open
$7.18
High
$7.18
Low
$6.73
Mkt. cap
13.18M
Avg. vol.
365.03K
Volume
8.67K
52-wk high
$25.99
52-wk low
$5.00
EPS
-$8.73
Beta
1.60
Shares outstanding
1.90M
No. of employees
17
News stories
From web sources and news partners
About Neurosense Therapeutics Ltd
CEO-
Employees17
Founded2017
Headquarters-
SectorBiotechnology
Websiteneurosense-tx.com
Analyst ratings
Based on 2 analysts giving stock ratings to NRSN in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for NRSN in the last 3 months.
Highest
Current $6.95
$9.00 (+29.50%)
Average
$8.50 (+22.30%)
Lowest
$8.00 (+15.11%)
Analyst
Recommendation
Action
Price target
Projected
Date
Lander Egana Gorrono
H.C. Wainwright
Buy
Initiated
$8.00
+15.1%
09/03/2026
Robert LeBoyer
Noble Financial
Buy
Reiterated
$9.00
+29.5%
08/11/2026
Boobalan Pachaiyappan
Roth MKM
Buy
Maintained
$3.00
-56.8%
06/10/2026
James Molloy
Alliance Global Partners
Buy
Reiterated
$7.50
+7.9%
02/19/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1.25M
1.25M
1.86M
1.86M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.09M
1.09M
1.33M
1.33M
Operating expense
2.35M
2.35M
3.20M
3.20M
Total operating expenses
2.35M
2.35M
3.20M
3.20M
Operating income
-2.35M
-2.35M
-3.20M
-3.20M
Other non operating income
-
-
-3.00K
-3.00K
EBT including unusual items
-2.35M
-2.35M
-3.21M
-3.21M
EBT excluding unusual items
-2.35M
-2.35M
-3.21M
-3.21M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-2.35M
-2.35M
-3.21M
-3.21M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
15.00K
15.00K
Interest expense
-8.50K
-8.50K
-
-
Net interest expenses
-8.50K
-8.50K
15.00K
15.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-2.34M
-2.34M
-3.19M
-3.19M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps